Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Forschner

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
International Journal of Cancer|July 20, 2024
Response and outcome of patients with melanoma skin metastases and immune checkpoint inhibitionAndrea Forschner, Lena Nanz, Yves Maczey-Leber, et al.
Cancer Medicine|March 24, 2025
Distress and Its Determinants in 820 Consecutive Melanoma PatientsMarkus Reitmajer, Petra Riedel, Claus Garbe, et al.
Journal of Cancer Research and Clinical Oncology|November 24, 2016
Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)Andrea Forschner, Felizitas Eichner, Teresa Amaral, et al.
Journal of the American Academy of Dermatology|July 2, 2003
Ulcerated epithelioid hemangioendothelioma of the foot in childhoodAndrea Forschner, Dieter Harms, Gisela Metzler, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2017
'Corrigendum to "Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins" [Eur J Cancer 81 (August 2017) 203-205]'Iris Spänkuch, Maximilian Gassenmaier, Ioanna Tampouri, et al.
Cancers|January 21, 2022
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic MelanomaMarcus Wölffer, Florian Battke, Martin Schulze, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 1, 2007
[G-DRG version 2007: a short overview]Marcel L Müller, Andrea Forschner, Thomas A Luger, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2017
Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulinsIris Spänkuch, Maximilian Gassenmaier, Ioanna Tampouri, et al.
Melanoma Research|March 11, 2010
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Cancers|October 28, 2023
Selective Internal Radiotherapy (SIRT) and Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) for Metastasized Uveal Melanoma: A Retrospective Comparative StudyManuel Kolb, Andrea Forschner, Christoph Artzner, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|July 20, 2024
Response and outcome of patients with melanoma skin metastases and immune checkpoint inhibitionAndrea Forschner, Lena Nanz, Yves Maczey-Leber, et al.
Cancer Medicine|March 24, 2025
Distress and Its Determinants in 820 Consecutive Melanoma PatientsMarkus Reitmajer, Petra Riedel, Claus Garbe, et al.
Journal of Cancer Research and Clinical Oncology|November 24, 2016
Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)Andrea Forschner, Felizitas Eichner, Teresa Amaral, et al.
Journal of the American Academy of Dermatology|July 2, 2003
Ulcerated epithelioid hemangioendothelioma of the foot in childhoodAndrea Forschner, Dieter Harms, Gisela Metzler, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2017
'Corrigendum to "Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins" [Eur J Cancer 81 (August 2017) 203-205]'Iris Spänkuch, Maximilian Gassenmaier, Ioanna Tampouri, et al.
Cancers|January 21, 2022
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic MelanomaMarcus Wölffer, Florian Battke, Martin Schulze, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 1, 2007
[G-DRG version 2007: a short overview]Marcel L Müller, Andrea Forschner, Thomas A Luger, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2017
Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulinsIris Spänkuch, Maximilian Gassenmaier, Ioanna Tampouri, et al.
Melanoma Research|March 11, 2010
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Cancers|October 28, 2023
Selective Internal Radiotherapy (SIRT) and Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) for Metastasized Uveal Melanoma: A Retrospective Comparative StudyManuel Kolb, Andrea Forschner, Christoph Artzner, et al.
Pageof 16